MRX-408

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameMRX-408
Drug Alias Namethrombus ultrasound agent (ImaRx)perfluoropropane gas-filled, GPIIb/IIIa-targeted nannobubbles (ImaRx)MRX-408A1MRX-408
ClassificationOther
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonistsBlood clotting modulators
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImarx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImarx Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A